Search
for
Sort by
Research 631–660 of 1000+
- Hair and scalp disorders in ethnic populations
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Hair and Scalp Manifestations in Secondary Syphilis: Epidemiology, Clinical Features and Trichoscopy
- New-onset Majocchi’s granuloma in two kidney transplant recipients under tacrolimus treatment
- Hair cosmetics
- Dermatologic care of the transgender patient
- Congenital hair loss disorders: Rare, but not too rare
- Dermoscopy: what's new?
- Temporal triangular alopecia: Trichoscopic diagnosis
- SKIN AND HAIR COSMETIC ISSUES IN WOMEN OF COLOR
- Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID ‐19 pandemic
- Diagnostic utility of dermatoscopy in hydroquinone‐induced exogenous ochronosis
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- Biomechanical properties of human hair with different parameters
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Localized syringolymphoid hyperplasia with alopecia and anhidrosis
- Allergic contact dermatitis from minoxidil
- Cutaneous Manifestations in Diabetes
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia
- Guidelines for management of androgenetic alopecia based on BASP classification-the Asian consensus committee guideline
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Incidence of Increased Androgen Levels in Patients Suffering from Acne
- Clinical features of primary cicatricial alopecia in Chinese patients
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia